Abstract
The Swedish healthcare system aims to provide equal access to care to all residents yet evidence suggests that patients with low socioeconomic status are less likely to receive new drugs. Associations between sociodemographics and prescription of non-vitamin K antagonist oral anticoagulants (NOACs) as an alternative to warfarin in Sweden have not been investigated. We conducted a cross-sectional study using linked national registers in Sweden. The study population included oral anticoagulant naïve patients aged ≥18 years with non-valvular atrial fibrillation (NVAF) who filled a first prescription for a NOAC or warfarin from 01 December 2011 to 31 December 2014. Multivariable logistic regression was used to identify factors associated with the choice of anticoagulant treatment; adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Among 68,056 patients with NVAF, 27.4% (N = 18,638) started treatment with a NOAC and 72.6% (N = 49,418) started on warfarin. Patients starting treatment with a NOAC were more likely to be highly educated (OR 1.37, 95% CI: 1.30-1.45), in the highest income quartile (OR 1.23, 95% CI: 1.16-1.31) and have a leading professional occupation (OR 1.41, 95% CI: 1.27-1.58). Patients re...Continue Reading
References
Apr 30, 2002·The Annals of Pharmacotherapy·Muhammad M MamdaniDavid A Alter
Jan 2, 2003·Family Practice·Helen ProsserTom Walley
Jun 15, 2005·Cancer Causes & Control : CCC·Magdalena LagerlundMats Lambe
Jun 29, 2005·European Journal of Clinical Pharmacology·Kvetoslava GoreckaIvan Tilser
Aug 13, 2008·European Journal of Clinical Pharmacology·Syed Imran HaiderJohan Fastbom
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Apr 15, 2010·Thorax·Anders BerglundMats Lambe
Jun 29, 2011·Scandinavian Journal of Primary Health Care·Alberto Ferro, Per M D Kristiansson
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 20, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anders BerglundMats Lambe
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Oct 2, 2012·Circulation Research·Calvin H YehJeffrey I Weitz
Jul 19, 2014·BMC Health Services Research·Azza AbuDaggaWilliam S Weintraub
Feb 26, 2016·PloS One·Michelle SholzbergAndreas Laupacis
Jun 20, 2017·American Heart Journal·Benjamin A SteinbergUNKNOWN Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients
Citations
Jan 30, 2021·Heart·Jelena KornejJared W Magnani
Jun 4, 2021·Nature Reviews. Cardiology·Utibe R EssienJared W Magnani
Jun 8, 2021·JAMA Network Open·Daniel M BlumenthalJoshua P Metlay
Aug 21, 2021·ClinicoEconomics and Outcomes Research : CEOR·Taru HallinenMikko Kosunen
Dec 17, 2021·British Journal of Clinical Pharmacology·Daniel Hill-McManus, Dyfrig A Hughes